| Patent application number | Description | Published |
|---|
| 20110310233 | Optimization of a Multi-View Display - Described herein is a multi-view display (based on spatial and/or temporal multiplexing) having an optimization mechanism that dynamically adjust views based upon detected state changes with respect to one or more views. The optimization mechanism determines viewing parameters (e.g., brightness and/or colors) for a view based upon a current position of the view, and/or on the multi-view display's capabilities. The state change may correspond to the view (a viewer's eye) moving towards another viewing zone, in which event new viewing parameters are determined, which may be in anticipation of entering the zone. Another state change corresponds to more views being needed than the display is capable of outputting, whereby one or more existing views are degraded, e.g., from 3D to 2D and/or from a personal video to a non-personal view. Conversely, a state change corresponding to excess capacity becoming available can result in enhancing a view to 3D and/or personal. | 12-22-2011 |
| 20110316984 | ADAPTIVE ADJUSTMENT OF DEPTH CUES IN A STEREO TELEPRESENCE SYSTEM - Described is a stereoscopic display (telepresence) system that includes a depth cue adjustment mechanism for changing screen disparity to move a fixation distance of a viewer (subject) closer to a focus distance, thereby providing more desirable viewing conditions. In one aspect, the depth cue adjustment mechanism adjusts a depth cue by moving the fixation distance forward, and/or by moving the focus distance backward. Also described is detecting encroachment, where the object is perceived as being too close to the subject viewer for comfort, and adjusting one or more depth cues (e.g., object scale) to counteract the sensation of the encroachment. | 12-29-2011 |
| Patent application number | Description | Published |
|---|
| 20080260727 | Modulation of Nkg2d - The present invention relates to methods and compositions for treating or preventing autoimmune and/or inflammatory disease. In particular, the present invention provides therapeutics for impairing the expansion and function of autoreactive T cells and/or NK cells, by modulating NKG2D. | 10-23-2008 |
| 20100183591 | MODULATION OF NKG2D - The present invention relates to methods and compositions for treating and/or preventing inflammation associated with viral infection and solid organ transplant rejection. In particular, the present invention provides therapeutics for impairing the expansion and function of autoreactive T cells, NK cells and/or NKT cells, by modulating NKG2D. | 07-22-2010 |
| 20120064070 | MODULATION OF NKG2D - The present invention relates to methods and compositions for treating and/or preventing autoimmune and/or inflammatory disease. In particular, the present invention provides therapeutics for impairing the expansion and function of autoreactive T cells, NK cells and/or NKT cells, by modulating NKG2D. | 03-15-2012 |
| 20120322668 | ASSESSMENT OF SOLID TUMOR BURDEN - The present disclosure is directed toward measurement of expression of one or both of an activating Natural Killer (NK) cell receptor and its ligand(s) on peripheral blood cells as a means to assess solid tumor burden. In particular, the present disclosure provides tools for assessing cancer recurrence or risk thereof following reduction of a solid tumor, and for developing a treatment regime for a cancer patient. | 12-20-2012 |
| Patent application number | Description | Published |
|---|
| 20080292623 | MAMMALIAN CELL MEMBRANE PROTEINS; RELATED REAGENTS - The purification and isolation of various genes which encode mammalian cell surface polypeptides. Nucleic acids, proteins, antibodies, and other reagents useful in modulating development of cells, e.g., lymphoid and myeloid, are provided, along with methods for their use. | 11-27-2008 |
| 20090012270 | OX2 RECEPTOR HOMOLOGS - Nucleic acids encoding mammalian, e.g., primate, receptors, purified proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are described. | 01-08-2009 |
| 20090263403 | MAMMALIAN CELL MEMBRANE PROTEINS; RELATED REAGENTS - The purification and isolation of various genes which encode mammalian cell surface polypeptides. Nucleic acids, proteins, antibodies, and other reagents useful in modulating development of cells, e.g., lymphoid and myeloid, are provided, along with methods for their use. | 10-22-2009 |
| 20100129374 | Mammalian Cell Membrane Proteins; Related Reagents - The purification and isolation of various genes which encode mammalian cell surface polypeptides. Nucleic acids, proteins, antibodies, and other reagents useful in modulating development of cells, e.g., lymphoid and myeloid, are provided, along with methods for their use. | 05-27-2010 |
| 20100209907 | ISOLATED MAMMALIAN MONOCYTE CELL GENES; RELATED REAGENTS - Nucleic acids encoding various monocyte cell proteins from a primate, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided. | 08-19-2010 |
| 20120020990 | ISOLATED MAMMALIAN MONOCYTE CELL GENES; RELATED REAGENTS - Nucleic acids encoding various monocyte cell proteins from a primate, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided. | 01-26-2012 |
| 20120231003 | Ox2 Receptor Homologs - Nucleic acids encoding mammalian, e.g., primate, receptors, purified proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are described. | 09-13-2012 |
| 20130034561 | ISOLATED MAMMALIAN MONOCYTE CELL GENES; RELATED REAGENTS - Nucleic acids encoding various monocyte cell proteins from a primate, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided. | 02-07-2013 |
